Abstract: Disclosed is a method of loading a signature rule and a network device thereof. According to an example of the method, the network device may first receive a signature rule library sent by a cloud server, wherein the signature rule library contains one or more signature rules, each of which is associated with corresponding device type configuration information. The network device may determine for each signature rule whether device type configuration information associated with the signature rule matches local device type configuration information of the network device. If the device type configuration information associated with the signature rule matches the local device type configuration information of the network device, the network device may load the signature rule.

Abstract: Disclosed are the development of a recombinant chicken IgY monoclonal antibody and a recombinant chicken IgY single-chain variable fragment (scFv) antibody raised against human thymidine kinase 1 in mammalian cells and a preparation method and use thereof. A light chain of the scFv antibody includes an amino acid sequence shown in SEQ ID NO: 1, and a heavy chain of the scFv antibody includes an amino acid sequence shown in SEQ ID NO: 2.

Abstract: Disclosed are the expression of a recombinant chicken IgY scFv antibody and monoclonal antibody raised against human thymidine kinase 1 (hTK1) in prokaryotic cells and a preparation method and use thereof. The scFv antibody includes an amino acid sequence shown in SEQ ID NO: 1. The anti-hTK1 recombinant scFv antibody and monoclonal antibody have good immunoreactivity, high specificity and sensitivity, and are easy to separate and purify.

Abstract: Disclosed are a kit and use thereof. The kit includes a first polyclonal antibody that has been immobilized or suitable for immobilization on a solid carrier, a second polyclonal antibody labeled with a marker. Both the first polyclonal antibody and the second polyclonal antibody are both chicken anti human-thymidine kinase IgY-polyclonal antibodies. Both the first polyclonal antibody and the second polyclonal antibody are suitable for specifically binding to thymidine kinase 1. The kit is suitable for the risk assessment of micro malignant tumors/precancerous diseases and tumors that are not detectable by human population screening images.

Abstract: Disclosed is a method of loading a signature rule and a network device thereof. According to an example of the method, the network device may first receive a signature rule library sent by a cloud server, wherein the signature rule library contains one or more signature rules, each of which is associated with corresponding device type configuration information. The network device may determine for each signature rule whether device type configuration information associated with the signature rule matches local device type configuration information of the network device. If the device type configuration information associated with the signature rule matches the local device type configuration information of the network device, the network device may load the signature rule.